rs72654423

Variant summary

Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_000384.3(APOB):​c.12940A>G​(p.Ile4314Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00766 in 1,611,112 control chromosomes in the GnomAD database, including 75 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.

Frequency

Genomes: 𝑓 0.0055 ( 3 hom., cov: 32)
Exomes 𝑓: 0.0079 ( 72 hom. )

Consequence

APOB
NM_000384.3 missense

Scores

16

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:16

Conservation

PhyloP100: -0.0850
Variant links:
Genes affected
APOB (HGNC:603): (apolipoprotein B) This gene product is the main apolipoprotein of chylomicrons and low density lipoproteins (LDL), and is the ligand for the LDL receptor. It occurs in plasma as two main isoforms, apoB-48 and apoB-100: the former is synthesized exclusively in the gut and the latter in the liver. The intestinal and the hepatic forms of apoB are encoded by a single gene from a single, very long mRNA. The two isoforms share a common N-terminal sequence. The shorter apoB-48 protein is produced after RNA editing of the apoB-100 transcript at residue 2180 (CAA->UAA), resulting in the creation of a stop codon, and early translation termination. Mutations in this gene or its regulatory region cause hypobetalipoproteinemia, normotriglyceridemic hypobetalipoproteinemia, and hypercholesterolemia due to ligand-defective apoB, diseases affecting plasma cholesterol and apoB levels. [provided by RefSeq, Dec 2019]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0038571954).
BP6
Variant 2-21002482-T-C is Benign according to our data. Variant chr2-21002482-T-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 237739.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=5, Benign=7, Uncertain_significance=3}. Variant chr2-21002482-T-C is described in Lovd as [Benign].
BS2
High Homozygotes in GnomAd4 at 3 SD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
APOBNM_000384.3 linkuse as main transcriptc.12940A>G p.Ile4314Val missense_variant 29/29 ENST00000233242.5

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
APOBENST00000233242.5 linkuse as main transcriptc.12940A>G p.Ile4314Val missense_variant 29/291 NM_000384.3 P1

Frequencies

GnomAD3 genomes
AF:
0.00550
AC:
837
AN:
152216
Hom.:
3
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00150
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00347
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00559
Gnomad FIN
AF:
0.00216
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.00976
Gnomad OTH
AF:
0.00239
GnomAD3 exomes
AF:
0.00537
AC:
1341
AN:
249874
Hom.:
13
AF XY:
0.00555
AC XY:
750
AN XY:
135242
show subpopulations
Gnomad AFR exome
AF:
0.00138
Gnomad AMR exome
AF:
0.00195
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00356
Gnomad FIN exome
AF:
0.00278
Gnomad NFE exome
AF:
0.00931
Gnomad OTH exome
AF:
0.00512
GnomAD4 exome
AF:
0.00788
AC:
11501
AN:
1458778
Hom.:
72
Cov.:
34
AF XY:
0.00775
AC XY:
5625
AN XY:
725836
show subpopulations
Gnomad4 AFR exome
AF:
0.00129
Gnomad4 AMR exome
AF:
0.00204
Gnomad4 ASJ exome
AF:
0.0000383
Gnomad4 EAS exome
AF:
0.0000504
Gnomad4 SAS exome
AF:
0.00370
Gnomad4 FIN exome
AF:
0.00289
Gnomad4 NFE exome
AF:
0.00945
Gnomad4 OTH exome
AF:
0.00642
GnomAD4 genome
AF:
0.00549
AC:
837
AN:
152334
Hom.:
3
Cov.:
32
AF XY:
0.00498
AC XY:
371
AN XY:
74508
show subpopulations
Gnomad4 AFR
AF:
0.00149
Gnomad4 AMR
AF:
0.00346
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.00559
Gnomad4 FIN
AF:
0.00216
Gnomad4 NFE
AF:
0.00976
Gnomad4 OTH
AF:
0.00237
Alfa
AF:
0.00671
Hom.:
3
Bravo
AF:
0.00501
TwinsUK
AF:
0.0119
AC:
44
ALSPAC
AF:
0.00882
AC:
34
ESP6500AA
AF:
0.00182
AC:
8
ESP6500EA
AF:
0.00942
AC:
81
ExAC
AF:
0.00587
AC:
712
EpiCase
AF:
0.00764
EpiControl
AF:
0.00836

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:16
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Hypercholesterolemia, familial, 1 Uncertain:2Benign:3
Uncertain significance, criteria provided, single submitterresearchFundacion Hipercolesterolemia FamiliarMar 01, 2016- -
Likely benign, criteria provided, single submitterclinical testingRobarts Research Institute, Western UniversityJan 02, 2018- -
Benign, criteria provided, single submitterclinical testingGenomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of PhiladelphiaOct 18, 2015- -
Likely benign, criteria provided, single submitterclinical testingColor Diagnostics, LLC DBA Color HealthJun 27, 2017- -
Uncertain significance, criteria provided, single submitterresearchLaboratory of Genetics and Molecular Cardiology, University of São PauloMar 01, 2016- -
not specified Benign:4
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Jan 18, 2017- -
Benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
Benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
not provided Benign:4
Likely benign, criteria provided, single submitterclinical testingGeneDxOct 01, 2020This variant is associated with the following publications: (PMID: 26415676, 27153395) -
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenJul 01, 2024APOB: BP4, BS2 -
Benign, criteria provided, single submitterclinical testingQuest Diagnostics Nichols Institute San Juan CapistranoMay 23, 2022- -
Likely benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesOct 02, 2023- -
Familial hypercholesterolemia Benign:2
Benign, criteria provided, single submitterclinical testingGENinCode PLCSep 26, 2022- -
Benign, no assertion criteria providedclinical testingCohesion PhenomicsFeb 09, 2023- -
Familial hypobetalipoproteinemia 1 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -
Hypercholesterolemia, autosomal dominant, type B;C4551990:Familial hypobetalipoproteinemia 1 Benign:1
Benign, criteria provided, single submitterclinical testingInvitaeFeb 01, 2024- -
Hypercholesterolemia, autosomal dominant, type B Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJul 11, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. -
Cardiovascular phenotype Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsJun 22, 2016This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.67
T
BayesDel_noAF
Benign
-0.73
CADD
Benign
0.59
DANN
Benign
0.58
Eigen
Benign
-1.0
Eigen_PC
Benign
-1.0
FATHMM_MKL
Benign
0.19
N
M_CAP
Benign
0.014
T
MetaRNN
Benign
0.0039
T
MetaSVM
Benign
-0.89
T
MutationTaster
Benign
1.0
N
PrimateAI
Benign
0.46
T
PROVEAN
Benign
-0.57
N
REVEL
Benign
0.010
Sift
Benign
0.28
T
Sift4G
Benign
0.82
T
Vest4
0.050
MVP
0.23
MPC
0.033
ClinPred
0.0032
T
GERP RS
-0.094
gMVP
0.12

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs72654423; hg19: chr2-21225354; API